Intuitive Surgical, Inc.

ISRG
$420.06 (- $30.00 - 6.67%)
Last updated: 2026-05-11 22:20 UTC
ISRG Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS46120E6023
CUSIP46120E602
Market Price420.06
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E Ratio52.53
EPS7.87
Market Cap$185.8B
Book Value47.7
Price to Book12.099
Beta-0.33
52w High603.88
52w Low417.74
Next Earnings DateN/A

Intuitive Surgical, Inc. trades under ticker ISRG on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US46120E6023, CUSIP 46120E602.

About the Company
Intuitive Surgical, Inc. is a medical technology company that develops, manufactures, and markets robotic-assisted systems designed to support minimally invasive care in hospitals and healthcare facilities worldwide. Its primary platforms include the da Vinci Surgical System, which enables surgeons to perform complex procedures through small incisions with enhanced precision, visualization, and control, and the Ion endoluminal system, which focuses on minimally invasive lung biopsies and diagnostic procedures. Intuitive Surgical provides a comprehensive ecosystem around these systems, including surgical instruments, disposable accessories, vision and imaging technologies, training, and technical support services. The company works closely with surgeons and healthcare providers across specialties such as urology, gynecology, general surgery, and thoracic care, aiming to broaden access to minimally invasive treatment options. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Price History
Latest News for ISRG
Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.
Intuitive Surgical is in its own bear market, which has historically been a good time for aggressive growth investors to buy.
Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
ISRG's da Vinci 5 is driving stronger utilization and procedure growth, but can higher throughput and after-hours surgeries sustain momentum?
Intuitive Surgical (ISRG) Is Among The Best Agentic AI Stocks To Buy Right Now
With an upside potential of 35.5%, Intuitive Surgical, Inc. (NASDAQ:ISRG) remains a bullish pick among analysts. The stock, therefore, earns its place on our list of the best agentic AI stocks to buy right now. On April 21, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported strong first-quarter results, exceeding Wall Street projections in both revenue and […]
Jim Cramer Discusses the Performance of Danaher and Its Peers
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
Intuitive Surgical Trades Near 2-Year Low: Is $600 Within Reach?
ISRG nears a key support level after a 23.7% YTD drop, but strong da Vinci 5 adoption and procedure growth may fuel a rebound.
What Intuitive Surgical (ISRG)'s FDA Class I Recall and Institutional Selling Mean For Shareholders
In recent months, Intuitive Surgical has faced FDA Class I recalls on certain da Vinci stapler components and visible institutional selling, reflecting elevated concern around product safety and regulatory scrutiny despite earlier strong quarterly results. These developments coincide with ongoing competition in surgical robotics and highlight how regulatory risk and large investor behavior can quickly influence perceptions of an otherwise growing, cash-generative business model. We’ll now...